Chemotherapy in combination with pembrolizumab and antiangiogenesis in young patients with advanced primary pulmonary mucinous adenocarcinoma: Two case …

D Zhou, W Gulinuer, N Zhu - Science Progress, 2021 - journals.sagepub.com
Primary pulmonary mucinous adenocarcinoma is an unusual histological type of non-small
cell lung cancer and has a rare prevalence at a young age. There is no standard first-line …

Optimizing palliative chemotherapy for advanced invasive mucinous adenocarcinoma of the lung

YJ Jang, D Hyun, CM Choi, DH Lee, SW Kim, S Yoon… - BMC cancer, 2021 - Springer
Background A primary pulmonary invasive mucinous adenocarcinoma (IMA) is a rare
subtype of invasive adenocarcinoma of the lung. The prognosis of advanced IMA depending …

Favorable treatment response of bevacizumab-combined chemotherapy for advanced or recurrent invasive mucinous adenocarcinoma of the lung: A retrospective …

K Fujimoto, A Sekine, E Hagiwara, M Asaoka… - Respiratory …, 2024 - Elsevier
Invasive mucinous adenocarcinoma (IMA) of the lung is a rare variant of adenocarcinoma
characterized by abundant intracytoplasmic mucin within the tumor. Although IMA has poor …

[HTML][HTML] Clinicopathological features of pulmonary mucinous adenocarcinoma: A descriptive analysis

M Bradbury, D Akurang, A Nasser, S Moore… - Cancer Treatment and …, 2022 - Elsevier
Background: Mucinous adenocarcinoma is a rare subtype of lung cancer characterized by
abnormal mucin production. We sought to investigate the clinical and pathological features …

Two cases of recurrent invasive mucinous adenocarcinoma of the lung showing marked responses to platinum-based chemotherapyregimens with pemetrexed and …

Y Koma, N Nakashima, M Koyama, K Goto… - Gan to Kagaku ryoho …, 2013 - europepmc.org
Here, we report 2 cases of recurrent invasive mucinous adenocarcinoma of the lung after
surgery, which showed marked responses to platinum-based regimens with pemetrexed …

Primary mucinous carcinomas of the lung: clinical characteristics and treatment outcomes

LK Rajeev, AGF Thottian, U Amirtham, D Lokanatha… - Lung India, 2020 - journals.lww.com
Materials and Methods: Medical records of patients diagnosed with IMA by needle biopsy at
Kidwai Cancer Institute, Bangalore, from 2013 to 2018, were retrieved and reviewed …

[HTML][HTML] Diagnosis, clinicopathological characteristics and prognosis of pulmonary mucinous adenocarcinoma

F Sun, P Wang, Y Zheng, W Jia, F Liu… - Oncology …, 2018 - spandidos-publications.com
Primary pulmonary mucinous adenocarcinoma (PPMA) is an uncommon subtype of lung
adenocarcinoma. The present study attempted to clarify the diagnosis, clinicopathological …

Efficacy of Systemic Treatments in Patients With Metastatic Lung Invasive Mucinous Adenocarcinoma

T Demir, M Araz, C Moloney, E Hendem, MZ Koçak… - Clinical Lung Cancer, 2024 - Elsevier
Background Invasive mucinous adenocarcinoma (IMA) is a rare histological subtype of lung
invasive adenocarcinoma with unique clinical, radiological, histopathological, and genomic …

A favorable response to cisplatin, pemetrexed and bevacizumab in two cases of invasive mucinous adenocarcinoma formerly known as pneumonic-type mucinous …

H Yamakawa, N Takayanagi, T Ishiguro… - Internal …, 2013 - jstage.jst.go.jp
The leading subtype of lung cancer, adenocarcinoma, received a new classification in 2011
when multifocal, pneumonic-type mucinous tumors, formerly called mucinous …

Pulmonary invasive mucinous adenocarcinoma mimicking pulmonary actinomycosis

D Zhu, Q Zhang, Z Rui, S Xu - BMC Pulmonary Medicine, 2022 - Springer
Background Primary pulmonary invasive mucinous adenocarcinoma is a rare and distinct
subtype of lung adenocarcinoma. Case presentation A 72-year-old woman presented with …